Cancer

Items 31-40 of 49

per page
Set Descending Direction
  1. anti-CD86 (human), mAb (BU63)
    ANC-307-020.
    ANC-307-020100 µg
    CHF 306.00
  2. anti-CD86 (human), mAb (BU63) (Biotin)
    ANC-307-030.
    ANC-307-030100 µg
    CHF 390.00
  3. anti-CD86 (human), mAb (BU63) (FITC)
    ANC-307-040.
    ANC-307-040120 tests
    CHF 390.00
  4. anti-CD86 (human), mAb (BU63) (preservative free)
    ANC-307-820.
    ANC-307-820100 µg
    CHF 306.00
  5. anti-CD86 (human), mAb (BU63) (R-PE)
    ANC-307-050.
    ANC-307-050120 tests
    CHF 455.00
  6. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  7. anti-Lewisy/b hapten (human), mAb (SC104) (preservative free)
    AG-20B-6002PF
    AG-20B-6002PF-C100100 µg
    CHF 470.00
  8. anti-Netrin-1 (human), mAb (rec.) (blocking) (2F5) (preservative-free)
    AG-27B-0018PF
    AG-27B-0018PF-C100100 µg
    CHF 420.00
    AG-27B-0018PF-C500500 µg
    CHF 1'140.00
    Schematic antibody structure of the recombinant antibody anti-Netrin-1 (human), mAb (rec.) (blocking) (2F5) (Prod. No. AG-27B-0018PF). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the antige
  9. anti-PD-1 (mouse), mAb (blocking) (1H10)
    AG-20B-0075
    AG-20B-0075-C100100 µg
    CHF 230.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  10. anti-PD-1 (mouse), mAb (blocking) (1H10) (preservative free)
    AG-20B-0075PF
    AG-20B-0075PF-C100100 µg
    CHF 230.00
    AG-20B-0075PF-C500500 µg
    CHF 400.00
    AG-20B-0075PF-M0022 mg
    CHF 590.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy

Items 31-40 of 49

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.